Inspire Medical Systems (NYSE:INSP) shares dipped today on third-quarter results that came in ahead of the consensus forecast ...

Inquis Medical announced that it closed a $40 million Series B financing round to support its advanced thrombectomy ...

Abbott (NYSE:ABT) today announced data demonstrating the long-term effectiveness of its Esprit BTK drug-eluting stent.

Johnson & Johnson MedTech's Shockwave Medical unit today announced the first clinical outcomes associated with its Javelin ...

Integra Lifesciences today announced it named Mojdeh Poul as president and CEO, effective January 6, 2025.

NeurAxis (NYSE:NRXS) announced today that the FDA granted an expanded 510(k) clearance for its IB-Stim non-implanted nerve ...

Medtronic (NYSE:MDT) announced results from two studies evaluating the utility of atherectomy for peripheral endovascular interventions.

The investment, announced Oct. 24, makes Ottoback (Duderstadt Germany) the largest shareholder in Onward Medical (Eindhoven, The Netherlands).

Akura Medical, a Shifamed portfolio company, announced today that the FDA granted its Katana system investigational device exemption (IDE).

Philips announced the first U.S. treatment using its new laser device that combines two peripheral artery disease (PAD) procedures into one.

R3 Vascular announced today that the FDA granted investigational device exemption (IDE) to evaluate its drug-eluting ...

Whiting succeeds Jill Schiaparelli, who served in the corner office since 2018. He takes over at the Columbus, Ohio-based non-invasive neuromodulation technology developer advancing a therapy for ...